Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates
09:04pm, Tuesday, 08'th Nov 2022
Seer, Inc. (SEER) delivered earnings and revenue surprises of 0% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2022 Results - Earnings Call Transcript
08:42pm, Tuesday, 08'th Nov 2022
Seer, Inc. (NASDAQ:SEER ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Chair and CEO David Horn - CFO Conference Call Partici
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
04:15pm, Thursday, 13'th Oct 2022
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fina
Seer to Participate in the Morgan Stanley Global Healthcare Conference
04:05pm, Tuesday, 30'th Aug 2022
REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company wi
Seer, Inc. (SEER) CEO Omid Farokhzad on Q2 2022 Results - Earnings Call Transcript
01:24pm, Saturday, 13'th Aug 2022
Seer, Inc. (NASDAQ:SEER ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Founder, Chairman & CEO David Horn - CFO Omead Ostadan -
Seer, Inc. (SEER) Reports Q2 Loss, Tops Revenue Estimates
09:04pm, Tuesday, 09'th Aug 2022
Seer, Inc. (SEER) delivered earnings and revenue surprises of 5.13% and 17.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Seer to Report Second Quarter 2022 Financial Results on August 9, 2022
04:05pm, Thursday, 14'th Jul 2022
REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report finan
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2022 Results - Earnings Call Transcript
11:01pm, Friday, 06'th May 2022
Seer, Inc. (NASDAQ:SEER ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Founder, Chairman & CEO David Horn - CFO Omead Ostadan - Pr
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Wednesday, 04'th May 2022
Seer, Inc. (SEER) delivered earnings and revenue surprises of 7.32% and 18.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Seer to Present at the BofA Securities 2022 Healthcare Conference
04:05pm, Thursday, 28'th Apr 2022
REDWOOD CITY, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company w
Seer to Report First Quarter Financial Results on May 4, 2022
04:05pm, Thursday, 07'th Apr 2022
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fina
Seer hires Scott Thomas as chief commercial officer
08:12pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Seer (SEER) appointed Scott D. Thomas as chief commercial officer effective Mar. 21. Thomas joins SEER from Singular Genomics, where he served as SVP, sales and marketing.
Seer stock falls despite Q4 revenue soaring 813% Y/Y
02:46pm, Tuesday, 01'st Mar 2022 Seeking Alpha
Seer <> stock fell despite Q4 revenues rose 812.5% Y/Y to $3.07M.The increase was due to growth in sales of the Proteograph Product Suite, including SP100 instruments, consumable…
Seer, Inc. (SEER) Q4 2021 Earnings Call Transcript
10:00am, Tuesday, 01'st Mar 2022 The Motley Fool
SEER earnings call for the period ending December 31, 2021.
